fda warning letters compounded semaglutide tirzepatide september 2025 A company called Nomida has received an letter for offering for sale injectable weight-loss treatments. None of their offerings are FDA-approved. Nomida is allegedly selling unapproved and "kits" U.S. FDA sends drug advertising

Compounded semaglutide has emerged as an alternative to Wegovy and Ozempic due to its lower cost and greater availability, says Paunel Vukasinov, MD, internist and obesity medicine specialist with Medical Offices of Manhattan

Festa Ortega JF, Heidor R, Auriemo AP, Marques Affonso J, Pereira D, Amico T, Herz C, de Conti A, Ract J, Gioieli LA, Purgatto E, et al

This adjustment phase is crucial as it helps to increase the effectiveness of the treatment

Alpha-Lipoic Acid (ALA): This molecule helps to regenerate other antioxidants, including Vitamin C and Vitamin E, further strengthening the protective shield

The injection, named Ozempic, is FDA-approved to reduce blood sugar levels in adults with type 2 diabetes